Changmao Biochemical Engineering Co Ltd ($954) - buy or sell? Stock discussion, ideas, forum

Changmao Biochemical Engineering Co Ltd

Changmao Biochemical Engineering Company Limited produces and sells organic acids, which are derived from maleic anhydride or crude maleic anhydride, and mainly used as pharmaceutical intermediates and/or food additives.

Industry: Chemicals

Ticker	Exchange	ISIN	Name
$954	HKEx Main Board	CNE100000106	Code: 954

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 954 stock

Share your investment idea or question on Changmao Biochemical Engineering Co Ltd stock:

Latest twits on Changmao Biochemical Engineering Co Ltd (954)

No twits yet. Be the first to post!

Have a question about 954? Ask and other investors will be eager to help you.

Have an idea about 954? Share it with other investors.

Changmao Biochemical Engineering Co Ltd news

08/03/2017 Changmao Biochemical Engineering Co Ltd Net Income dropped on 26.7% while Revenue surged on 15.5%

16/03/2016 Changmao Biochemical Engineering Co Ltd reports 52.9% CAPEX decline and 8.3% Revenue decline

Changmao Biochemical Engineering Co Ltd stock price chart

Changmao Biochemical Engineering Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	515.6	620.2	653.2
EBITDA	114.6	94.372	103.0
Net income	75.773	41.105	49.455
CAPEX	3.143	51.729	42.115
Debt	123.5	181.9	144.5
Cash	47.150	59.635	108.2